Abstract
Lipids, one of the major natural products, usually have high biocompatibility and low toxicity. Due to their proper physicochemical properties, they are the most commonly used materials for building modern drug delivery systems, especially nanocarriers. However, to impart new functions or to satisfy special requirements, the lipids can be modified or synthesized. Using lipids or lipid derivatives, various lipid-based drug or gene delivery systems have been developed and show potential in pre-clinical and clinical applications. In this article, the most commonly used lipids are discussed in terms of their properties and functions as drug carrier components, their chemical modifications, the formulation or composition of lipid-based nanocarriers, and their biomedical applications. This article provides a critical view and possible future directions of lipid-based drug delivery strategies.
Keywords: Drug delivery, gene delivery, lipids, lipid conjugate, lipid derivatives, nanocarrier, natural product.
Current Drug Targets
Title:Lipids and Their Derivatives: By-Products Used as Essential Building Blocks for Modern Drug Delivery Systems
Volume: 15 Issue: 5
Author(s): Ying Tu and Lin Zhu
Affiliation:
Keywords: Drug delivery, gene delivery, lipids, lipid conjugate, lipid derivatives, nanocarrier, natural product.
Abstract: Lipids, one of the major natural products, usually have high biocompatibility and low toxicity. Due to their proper physicochemical properties, they are the most commonly used materials for building modern drug delivery systems, especially nanocarriers. However, to impart new functions or to satisfy special requirements, the lipids can be modified or synthesized. Using lipids or lipid derivatives, various lipid-based drug or gene delivery systems have been developed and show potential in pre-clinical and clinical applications. In this article, the most commonly used lipids are discussed in terms of their properties and functions as drug carrier components, their chemical modifications, the formulation or composition of lipid-based nanocarriers, and their biomedical applications. This article provides a critical view and possible future directions of lipid-based drug delivery strategies.
Export Options
About this article
Cite this article as:
Tu Ying and Zhu Lin, Lipids and Their Derivatives: By-Products Used as Essential Building Blocks for Modern Drug Delivery Systems, Current Drug Targets 2014; 15 (5) . https://dx.doi.org/10.2174/1389450115666140306154120
DOI https://dx.doi.org/10.2174/1389450115666140306154120 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Multifaceted Activities of Mammalian Defensins
Current Pharmaceutical Design High Glucose Enhances Neurotoxicity and Inflammatory Cytokine Secretion by Stimulated Human Astrocytes
Current Alzheimer Research Combining Cytotoxic and Immune-Mediated Gene Therapy to Treat Brain Tumors
Current Topics in Medicinal Chemistry Therapeutic Modulation of Cytokines in Chronic Infectious Diseases
Current Pharmaceutical Design Metallic Colloid Nanotechnology, Applications in Diagnosis and Therapeutics
Current Pharmaceutical Design Group A Streptococcal Infections in Children
Current Pediatric Reviews Mast Cells and Basophils: Trojan Horses of Conventional Lin- Stem/Progenitor Cell Isolates
Current Pharmaceutical Design Antifungal Drug Discovery through the Study of Invertebrate Model Hosts
Current Medicinal Chemistry Humanized Mouse Models of HIV-1 Latency
Current HIV Research Targeted Vascular Drug Delivery in Cerebral Cancer
Current Pharmaceutical Design Transient Opening of the Blood-Brain Barrier by Vasoactive Peptides to Increase CNS Drug Delivery: Reality Versus Wishful Thinking?
Current Neuropharmacology Multiple Roles of the Extracellular Matrix in Inflammation
Current Pharmaceutical Design Recent Advances in the Discovery of Novel Anti-Herpetic Agents from Chinese Herbal Medicines
Current Organic Chemistry Rediscovering the Antibiotics of the Hive
Recent Patents on Anti-Infective Drug Discovery The Controversial Role of Adenosine A2A Receptor Antagonists as Neuro-protective Agents
Current Medicinal Chemistry - Central Nervous System Agents Wzy-Dependent Bacterial Capsules as Potential Drug Targets
Current Drug Targets Can Mycobacterial Genomics Generate Novel Targets as Speed-Breakers Against the Race for Drug Resistance
Current Pharmaceutical Design Ectopic ATP Synthase in Endothelial Cells: A Novel Cardiovascular Therapeutic Target
Current Pharmaceutical Design Relevance of Pharmacokinetic and Pharmacodynamic Modeling to Clinical Care of Critically Ill Patients
Current Pharmaceutical Biotechnology Actions of Melatonin, Its Structural and Functional Analogs in the Central Nervous System and the Significance of Metabolism
Central Nervous System Agents in Medicinal Chemistry